nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0295	0.0418	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0295	0.0418	CbGbCtD
Iloperidone—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0255	0.0361	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0255	0.0361	CbGbCtD
Iloperidone—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0247	0.035	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0247	0.035	CbGbCtD
Iloperidone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0245	0.0347	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0224	0.0317	CbGbCtD
Iloperidone—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0224	0.0317	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0224	0.0317	CbGbCtD
Iloperidone—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0224	0.0317	CbGbCtD
Iloperidone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0221	0.0313	CbGbCtD
Iloperidone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0221	0.0313	CbGbCtD
Iloperidone—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0216	0.0306	CbGbCtD
Iloperidone—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0194	0.0274	CbGbCtD
Iloperidone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0191	0.0271	CbGbCtD
Iloperidone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0186	0.0263	CbGbCtD
Iloperidone—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0182	0.0258	CbGbCtD
Iloperidone—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0182	0.0258	CbGbCtD
Iloperidone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0168	0.0238	CbGbCtD
Iloperidone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0168	0.0238	CbGbCtD
Iloperidone—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0165	0.0233	CbGbCtD
Iloperidone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.016	0.0226	CbGbCtD
Iloperidone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.015	0.0213	CbGbCtD
Iloperidone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.015	0.0213	CbGbCtD
Iloperidone—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0138	0.0195	CbGbCtD
Iloperidone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0136	0.0192	CbGbCtD
Iloperidone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0136	0.0192	CbGbCtD
Iloperidone—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0125	0.0177	CbGbCtD
Iloperidone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0117	0.0166	CbGbCtD
Iloperidone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0114	0.0161	CbGbCtD
Iloperidone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0103	0.0146	CbGbCtD
Iloperidone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0103	0.0146	CbGbCtD
Iloperidone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0102	0.0144	CbGbCtD
Iloperidone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00955	0.0135	CbGbCtD
Iloperidone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00955	0.0135	CbGbCtD
Iloperidone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00864	0.0122	CbGbCtD
Iloperidone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00864	0.0122	CbGbCtD
Iloperidone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00746	0.0105	CbGbCtD
Iloperidone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00724	0.0102	CbGbCtD
Iloperidone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00655	0.00926	CbGbCtD
Iloperidone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00655	0.00926	CbGbCtD
Iloperidone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00628	0.00888	CbGbCtD
Iloperidone—DRD1—nerve—acquired immunodeficiency syndrome	0.00248	0.0478	CbGeAlD
Iloperidone—HTR7—nerve—acquired immunodeficiency syndrome	0.00155	0.0299	CbGeAlD
Iloperidone—DRD2—nerve—acquired immunodeficiency syndrome	0.00147	0.0282	CbGeAlD
Iloperidone—HTR7—endothelium—acquired immunodeficiency syndrome	0.00132	0.0254	CbGeAlD
Iloperidone—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00123	0.0236	CbGeAlD
Iloperidone—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00117	0.0226	CbGeAlD
Iloperidone—HTR2A—nerve—acquired immunodeficiency syndrome	0.000968	0.0186	CbGeAlD
Iloperidone—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000936	0.018	CbGeAlD
Iloperidone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000903	0.0174	CbGeAlD
Iloperidone—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000861	0.0166	CbGeAlD
Iloperidone—DRD4—brain—acquired immunodeficiency syndrome	0.000849	0.0163	CbGeAlD
Iloperidone—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000842	0.0162	CbGeAlD
Iloperidone—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000824	0.0159	CbGeAlD
Iloperidone—DRD3—nervous system—acquired immunodeficiency syndrome	0.00078	0.015	CbGeAlD
Iloperidone—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000751	0.0144	CbGeAlD
Iloperidone—HTR6—nervous system—acquired immunodeficiency syndrome	0.000751	0.0144	CbGeAlD
Iloperidone—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000732	0.0141	CbGeAlD
Iloperidone—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000723	0.0139	CbGeAlD
Iloperidone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000678	0.013	CbGeAlD
Iloperidone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000667	0.0128	CbGeAlD
Iloperidone—DRD2—retina—acquired immunodeficiency syndrome	0.000608	0.0117	CbGeAlD
Iloperidone—DRD3—brain—acquired immunodeficiency syndrome	0.000596	0.0115	CbGeAlD
Iloperidone—HTR6—brain—acquired immunodeficiency syndrome	0.000574	0.011	CbGeAlD
Iloperidone—DRD1—nervous system—acquired immunodeficiency syndrome	0.000559	0.0107	CbGeAlD
Iloperidone—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000538	0.0103	CbGeAlD
Iloperidone—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000515	0.00991	CbGeAlD
Iloperidone—SIGMAR1—blood—acquired immunodeficiency syndrome	0.000503	0.00968	CbGeAlD
Iloperidone—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.000487	0.00937	CbGeAlD
Iloperidone—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.000485	0.00933	CbGeAlD
Iloperidone—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000467	0.00897	CbGeAlD
Iloperidone—HTR7—digestive system—acquired immunodeficiency syndrome	0.000451	0.00868	CbGeAlD
Iloperidone—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000441	0.00849	CbGeAlD
Iloperidone—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000441	0.00848	CbGeAlD
Iloperidone—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000438	0.00843	CbGeAlD
Iloperidone—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000434	0.00835	CbGeAlD
Iloperidone—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000434	0.00834	CbGeAlD
Iloperidone—HTR7—blood—acquired immunodeficiency syndrome	0.00043	0.00827	CbGeAlD
Iloperidone—DRD1—brain—acquired immunodeficiency syndrome	0.000427	0.00821	CbGeAlD
Iloperidone—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000422	0.00812	CbGeAlD
Iloperidone—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000418	0.00804	CbGeAlD
Iloperidone—ADRA1A—blood—acquired immunodeficiency syndrome	0.000415	0.00798	CbGeAlD
Iloperidone—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000414	0.00797	CbGeAlD
Iloperidone—HTR2A—retina—acquired immunodeficiency syndrome	0.000401	0.00771	CbGeAlD
Iloperidone—ADRA2C—blood—acquired immunodeficiency syndrome	0.000395	0.0076	CbGeAlD
Iloperidone—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000381	0.00732	CbGeAlD
Iloperidone—HTR7—lung—acquired immunodeficiency syndrome	0.000377	0.00725	CbGeAlD
Iloperidone—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000366	0.00705	CbGeAlD
Iloperidone—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000365	0.00703	CbGeAlD
Iloperidone—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00036	0.00692	CbGeAlD
Iloperidone—DRD2—lung—acquired immunodeficiency syndrome	0.000356	0.00686	CbGeAlD
Iloperidone—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000352	0.00676	CbGeAlD
Iloperidone—HTR7—nervous system—acquired immunodeficiency syndrome	0.000349	0.00671	CbGeAlD
Iloperidone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000347	0.00668	CbGeAlD
Iloperidone—ADRA2C—lung—acquired immunodeficiency syndrome	0.000347	0.00666	CbGeAlD
Iloperidone—CYP1A2—blood—acquired immunodeficiency syndrome	0.000343	0.0066	CbGeAlD
Iloperidone—HRH1—digestive system—acquired immunodeficiency syndrome	0.000337	0.00648	CbGeAlD
Iloperidone—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000337	0.00648	CbGeAlD
Iloperidone—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000336	0.00646	CbGeAlD
Iloperidone—HTR1D—brain—acquired immunodeficiency syndrome	0.000335	0.00644	CbGeAlD
Iloperidone—HTR2C—brain—acquired immunodeficiency syndrome	0.000332	0.00638	CbGeAlD
Iloperidone—CYP3A5—blood—acquired immunodeficiency syndrome	0.000331	0.00636	CbGeAlD
Iloperidone—DRD2—nervous system—acquired immunodeficiency syndrome	0.00033	0.00635	CbGeAlD
Iloperidone—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000328	0.00631	CbGeAlD
Iloperidone—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000324	0.00624	CbGeAlD
Iloperidone—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000324	0.00623	CbGeAlD
Iloperidone—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000321	0.00617	CbGeAlD
Iloperidone—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000318	0.00611	CbGeAlD
Iloperidone—ADRA2A—blood—acquired immunodeficiency syndrome	0.000315	0.00607	CbGeAlD
Iloperidone—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000312	0.00601	CbGeAlD
Iloperidone—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000309	0.00594	CbGeAlD
Iloperidone—CYP2E1—blood—acquired immunodeficiency syndrome	0.000309	0.00593	CbGeAlD
Iloperidone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000307	0.0059	CbGeAlD
Iloperidone—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000304	0.00584	CbGeAlD
Iloperidone—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000302	0.0058	CbGeAlD
Iloperidone—CYP1A2—lung—acquired immunodeficiency syndrome	0.000301	0.00578	CbGeAlD
Iloperidone—HRH1—vagina—acquired immunodeficiency syndrome	0.000298	0.00572	CbGeAlD
Iloperidone—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000297	0.00572	CbGeAlD
Iloperidone—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000292	0.00562	CbGeAlD
Iloperidone—CYP3A5—lung—acquired immunodeficiency syndrome	0.00029	0.00558	CbGeAlD
Iloperidone—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000282	0.00541	CbGeAlD
Iloperidone—HRH1—lung—acquired immunodeficiency syndrome	0.000282	0.00541	CbGeAlD
Iloperidone—HTR1A—brain—acquired immunodeficiency syndrome	0.000279	0.00537	CbGeAlD
Iloperidone—ADRA2A—lung—acquired immunodeficiency syndrome	0.000277	0.00532	CbGeAlD
Iloperidone—CYP2E1—lung—acquired immunodeficiency syndrome	0.000271	0.0052	CbGeAlD
Iloperidone—HTR2A—blood—acquired immunodeficiency syndrome	0.000268	0.00516	CbGeAlD
Iloperidone—HTR7—brain—acquired immunodeficiency syndrome	0.000267	0.00513	CbGeAlD
Iloperidone—HRH1—nervous system—acquired immunodeficiency syndrome	0.000261	0.00501	CbGeAlD
Iloperidone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000261	0.00501	CbGeAlD
Iloperidone—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000258	0.00497	CbGeAlD
Iloperidone—ADRA1A—brain—acquired immunodeficiency syndrome	0.000257	0.00495	CbGeAlD
Iloperidone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000256	0.00493	CbGeAlD
Iloperidone—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000256	0.00492	CbGeAlD
Iloperidone—DRD2—brain—acquired immunodeficiency syndrome	0.000252	0.00485	CbGeAlD
Iloperidone—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000251	0.00483	CbGeAlD
Iloperidone—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000251	0.00482	CbGeAlD
Iloperidone—HTR2A—vagina—acquired immunodeficiency syndrome	0.000249	0.00478	CbGeAlD
Iloperidone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000248	0.00478	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000247	0.00125	CcSEcCtD
Iloperidone—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.00125	CcSEcCtD
Iloperidone—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.00125	CcSEcCtD
Iloperidone—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000247	0.00474	CbGeAlD
Iloperidone—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.00124	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000246	0.00124	CcSEcCtD
Iloperidone—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000246	0.00124	CcSEcCtD
Iloperidone—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.00124	CcSEcCtD
Iloperidone—ADRA2C—brain—acquired immunodeficiency syndrome	0.000245	0.00472	CbGeAlD
Iloperidone—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000245	0.00124	CcSEcCtD
Iloperidone—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000245	0.00124	CcSEcCtD
Iloperidone—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00124	CcSEcCtD
Iloperidone—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.00123	CcSEcCtD
Iloperidone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000244	0.0047	CbGeAlD
Iloperidone—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000244	0.00123	CcSEcCtD
Iloperidone—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00123	CcSEcCtD
Iloperidone—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.00123	CcSEcCtD
Iloperidone—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000242	0.00122	CcSEcCtD
Iloperidone—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00122	CcSEcCtD
Iloperidone—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000242	0.00122	CcSEcCtD
Iloperidone—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000241	0.00122	CcSEcCtD
Iloperidone—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000241	0.00464	CbGeAlD
Iloperidone—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.00121	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000239	0.0012	CcSEcCtD
Iloperidone—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Iloperidone—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Iloperidone—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Iloperidone—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Iloperidone—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Iloperidone—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000237	0.00456	CbGeAlD
Iloperidone—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Iloperidone—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00119	CcSEcCtD
Iloperidone—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Iloperidone—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Iloperidone—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.00119	CcSEcCtD
Iloperidone—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000235	0.00119	CcSEcCtD
Iloperidone—HTR2A—lung—acquired immunodeficiency syndrome	0.000235	0.00452	CbGeAlD
Iloperidone—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.00119	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Iloperidone—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Iloperidone—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Iloperidone—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.00117	CcSEcCtD
Iloperidone—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000232	0.00117	CcSEcCtD
Iloperidone—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000232	0.00117	CcSEcCtD
Iloperidone—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00117	CcSEcCtD
Iloperidone—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00117	CcSEcCtD
Iloperidone—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00116	CcSEcCtD
Iloperidone—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00116	CcSEcCtD
Iloperidone—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Iloperidone—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Iloperidone—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Iloperidone—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Iloperidone—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Iloperidone—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00115	CcSEcCtD
Iloperidone—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000227	0.00115	CcSEcCtD
Iloperidone—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.00114	CcSEcCtD
Iloperidone—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.00114	CcSEcCtD
Iloperidone—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000224	0.00113	CcSEcCtD
Iloperidone—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00112	CcSEcCtD
Iloperidone—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00112	CcSEcCtD
Iloperidone—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00112	CcSEcCtD
Iloperidone—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.00112	CcSEcCtD
Iloperidone—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00111	CcSEcCtD
Iloperidone—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00111	CcSEcCtD
Iloperidone—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00111	CcSEcCtD
Iloperidone—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00022	0.00111	CcSEcCtD
Iloperidone—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Iloperidone—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Iloperidone—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.0011	CcSEcCtD
Iloperidone—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000218	0.0011	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000218	0.0011	CcSEcCtD
Iloperidone—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.0011	CcSEcCtD
Iloperidone—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000218	0.0011	CcSEcCtD
Iloperidone—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000218	0.00419	CbGeAlD
Iloperidone—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000217	0.0011	CcSEcCtD
Iloperidone—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.0011	CcSEcCtD
Iloperidone—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.00109	CcSEcCtD
Iloperidone—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00109	CcSEcCtD
Iloperidone—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.00108	CcSEcCtD
Iloperidone—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000215	0.00108	CcSEcCtD
Iloperidone—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Iloperidone—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Iloperidone—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.00108	CcSEcCtD
Iloperidone—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.00107	CcSEcCtD
Iloperidone—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.00107	CcSEcCtD
Iloperidone—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00106	CcSEcCtD
Iloperidone—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Iloperidone—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Iloperidone—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Iloperidone—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00021	0.00403	CbGeAlD
Iloperidone—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Iloperidone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000207	0.00104	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.00104	CcSEcCtD
Iloperidone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.00104	CcSEcCtD
Iloperidone—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.00104	CcSEcCtD
Iloperidone—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00104	CcSEcCtD
Iloperidone—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.00104	CcSEcCtD
Iloperidone—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.00104	CcSEcCtD
Iloperidone—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00104	CcSEcCtD
Iloperidone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000205	0.00103	CcSEcCtD
Iloperidone—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.00103	CcSEcCtD
Iloperidone—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.00103	CcSEcCtD
Iloperidone—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Iloperidone—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Iloperidone—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Iloperidone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000202	0.00388	CbGeAlD
Iloperidone—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00102	CcSEcCtD
Iloperidone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.00102	CcSEcCtD
Iloperidone—Rash—Didanosine—acquired immunodeficiency syndrome	0.0002	0.00101	CcSEcCtD
Iloperidone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.00101	CcSEcCtD
Iloperidone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.0002	0.00101	CcSEcCtD
Iloperidone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0002	0.00101	CcSEcCtD
Iloperidone—HRH1—brain—acquired immunodeficiency syndrome	0.000199	0.00383	CbGeAlD
Iloperidone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000199	0.001	CcSEcCtD
Iloperidone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.001	CcSEcCtD
Iloperidone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000198	0.00381	CbGeAlD
Iloperidone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000198	0.001	CcSEcCtD
Iloperidone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000198	0.000998	CcSEcCtD
Iloperidone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000197	0.000997	CcSEcCtD
Iloperidone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000996	CcSEcCtD
Iloperidone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000993	CcSEcCtD
Iloperidone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000992	CcSEcCtD
Iloperidone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000991	CcSEcCtD
Iloperidone—ADRA2A—brain—acquired immunodeficiency syndrome	0.000196	0.00376	CbGeAlD
Iloperidone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.000986	CcSEcCtD
Iloperidone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000195	0.000983	CcSEcCtD
Iloperidone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000981	CcSEcCtD
Iloperidone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000981	CcSEcCtD
Iloperidone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000194	0.00373	CbGeAlD
Iloperidone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000978	CcSEcCtD
Iloperidone—HRH1—lymph node—acquired immunodeficiency syndrome	0.000193	0.0037	CbGeAlD
Iloperidone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000971	CcSEcCtD
Iloperidone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000192	0.00097	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000968	CcSEcCtD
Iloperidone—CYP2E1—brain—acquired immunodeficiency syndrome	0.000191	0.00368	CbGeAlD
Iloperidone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000191	0.00367	CbGeAlD
Iloperidone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000959	CcSEcCtD
Iloperidone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.000956	CcSEcCtD
Iloperidone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.000955	CcSEcCtD
Iloperidone—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000189	0.00364	CbGeAlD
Iloperidone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000954	CcSEcCtD
Iloperidone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000189	0.000952	CcSEcCtD
Iloperidone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000189	0.000952	CcSEcCtD
Iloperidone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.00095	CcSEcCtD
Iloperidone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.00095	CcSEcCtD
Iloperidone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000948	CcSEcCtD
Iloperidone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000947	CcSEcCtD
Iloperidone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000947	CcSEcCtD
Iloperidone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000945	CcSEcCtD
Iloperidone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000944	CcSEcCtD
Iloperidone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000944	CcSEcCtD
Iloperidone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00094	CcSEcCtD
Iloperidone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000186	0.000938	CcSEcCtD
Iloperidone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000184	0.000927	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000926	CcSEcCtD
Iloperidone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000923	CcSEcCtD
Iloperidone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000183	0.000923	CcSEcCtD
Iloperidone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000922	CcSEcCtD
Iloperidone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000182	0.00092	CcSEcCtD
Iloperidone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000918	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000917	CcSEcCtD
Iloperidone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000916	CcSEcCtD
Iloperidone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000913	CcSEcCtD
Iloperidone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000912	CcSEcCtD
Iloperidone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00018	0.000909	CcSEcCtD
Iloperidone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00018	0.000908	CcSEcCtD
Iloperidone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000906	CcSEcCtD
Iloperidone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00018	0.000906	CcSEcCtD
Iloperidone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000905	CcSEcCtD
Iloperidone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000904	CcSEcCtD
Iloperidone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000901	CcSEcCtD
Iloperidone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000901	CcSEcCtD
Iloperidone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000899	CcSEcCtD
Iloperidone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000889	CcSEcCtD
Iloperidone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000887	CcSEcCtD
Iloperidone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000881	CcSEcCtD
Iloperidone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.00088	CcSEcCtD
Iloperidone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.000879	CcSEcCtD
Iloperidone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000879	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000878	CcSEcCtD
Iloperidone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000174	0.000877	CcSEcCtD
Iloperidone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000877	CcSEcCtD
Iloperidone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000174	0.000876	CcSEcCtD
Iloperidone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000876	CcSEcCtD
Iloperidone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.00087	CcSEcCtD
Iloperidone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000868	CcSEcCtD
Iloperidone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000864	CcSEcCtD
Iloperidone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000863	CcSEcCtD
Iloperidone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000863	CcSEcCtD
Iloperidone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000858	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000857	CcSEcCtD
Iloperidone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00017	0.000856	CcSEcCtD
Iloperidone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000847	CcSEcCtD
Iloperidone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000846	CcSEcCtD
Iloperidone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000844	CcSEcCtD
Iloperidone—HTR2A—brain—acquired immunodeficiency syndrome	0.000166	0.0032	CbGeAlD
Iloperidone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00084	CcSEcCtD
Iloperidone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000838	CcSEcCtD
Iloperidone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000838	CcSEcCtD
Iloperidone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000836	CcSEcCtD
Iloperidone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000164	0.000829	CcSEcCtD
Iloperidone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.000827	CcSEcCtD
Iloperidone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000164	0.000826	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000824	CcSEcCtD
Iloperidone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000161	0.000814	CcSEcCtD
Iloperidone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000813	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000812	CcSEcCtD
Iloperidone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000811	CcSEcCtD
Iloperidone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000807	CcSEcCtD
Iloperidone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000807	CcSEcCtD
Iloperidone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000807	CcSEcCtD
Iloperidone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000805	CcSEcCtD
Iloperidone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000804	CcSEcCtD
Iloperidone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.0008	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000787	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000781	CcSEcCtD
Iloperidone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.00078	CcSEcCtD
Iloperidone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000775	CcSEcCtD
Iloperidone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000775	CcSEcCtD
Iloperidone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.00077	CcSEcCtD
Iloperidone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000152	0.00077	CcSEcCtD
Iloperidone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000767	CcSEcCtD
Iloperidone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000152	0.00292	CbGeAlD
Iloperidone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000763	CcSEcCtD
Iloperidone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000762	CcSEcCtD
Iloperidone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000762	CcSEcCtD
Iloperidone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000746	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000745	CcSEcCtD
Iloperidone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000744	CcSEcCtD
Iloperidone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000744	CcSEcCtD
Iloperidone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000743	CcSEcCtD
Iloperidone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000729	CcSEcCtD
Iloperidone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000727	CcSEcCtD
Iloperidone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000718	CcSEcCtD
Iloperidone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000715	CcSEcCtD
Iloperidone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000711	CcSEcCtD
Iloperidone—Rash—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000709	CcSEcCtD
Iloperidone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000708	CcSEcCtD
Iloperidone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000703	CcSEcCtD
Iloperidone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000696	CcSEcCtD
Iloperidone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000682	CcSEcCtD
Iloperidone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000675	CcSEcCtD
Iloperidone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000672	CcSEcCtD
Iloperidone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.00067	CcSEcCtD
Iloperidone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000669	CcSEcCtD
Iloperidone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000668	CcSEcCtD
Iloperidone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000649	CcSEcCtD
Iloperidone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000643	CcSEcCtD
Iloperidone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000641	CcSEcCtD
Iloperidone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.00064	CcSEcCtD
Iloperidone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000631	CcSEcCtD
Iloperidone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000622	CcSEcCtD
Iloperidone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000619	CcSEcCtD
Iloperidone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000619	CcSEcCtD
Iloperidone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000604	CcSEcCtD
Iloperidone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000598	CcSEcCtD
Iloperidone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000593	CcSEcCtD
Iloperidone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000592	CcSEcCtD
Iloperidone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000591	CcSEcCtD
Iloperidone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000571	CcSEcCtD
Iloperidone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000571	CcSEcCtD
Iloperidone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.00057	CcSEcCtD
Iloperidone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000558	CcSEcCtD
Iloperidone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000544	CcSEcCtD
Iloperidone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000544	CcSEcCtD
Iloperidone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000538	CcSEcCtD
Iloperidone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000513	CcSEcCtD
Iloperidone—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.14e-05	0.000497	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.14e-05	0.000496	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.14e-05	0.000496	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.000495	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.13e-05	0.000495	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.13e-05	0.000494	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.13e-05	0.000494	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.13e-05	0.000493	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.12e-05	0.000493	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.000487	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.000486	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.09e-05	0.000485	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.09e-05	0.000485	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.09e-05	0.000483	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.07e-05	0.000481	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.07e-05	0.00048	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.06e-05	0.000478	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.04e-05	0.000473	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	2.04e-05	0.000472	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.03e-05	0.000471	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.01e-05	0.000466	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.01e-05	0.000465	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2e-05	0.000464	CbGpPWpGaD
Iloperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.98e-05	0.000459	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.98e-05	0.000459	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.98e-05	0.000458	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.98e-05	0.000458	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.98e-05	0.000458	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.97e-05	0.000457	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.97e-05	0.000457	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.97e-05	0.000457	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.97e-05	0.000457	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.96e-05	0.000454	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.96e-05	0.000454	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.95e-05	0.000451	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.95e-05	0.000451	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.95e-05	0.000451	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.89e-05	0.000438	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.89e-05	0.000438	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.88e-05	0.000436	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.000434	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.87e-05	0.000433	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.86e-05	0.000431	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.86e-05	0.00043	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.85e-05	0.000428	CbGpPWpGaD
Iloperidone—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.84e-05	0.000428	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.000422	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.000422	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.81e-05	0.000419	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.81e-05	0.000419	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.81e-05	0.000419	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.79e-05	0.000416	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.79e-05	0.000416	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.79e-05	0.000415	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.79e-05	0.000414	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.78e-05	0.000414	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.76e-05	0.000409	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.76e-05	0.000408	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.75e-05	0.000407	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.73e-05	0.000401	CbGpPWpGaD
Iloperidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.72e-05	0.000399	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.72e-05	0.000399	CbGpPWpGaD
Iloperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.72e-05	0.000398	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.71e-05	0.000397	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.7e-05	0.000394	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.7e-05	0.000394	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.7e-05	0.000393	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.69e-05	0.000391	CbGpPWpGaD
Iloperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.68e-05	0.00039	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.68e-05	0.000389	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.68e-05	0.000389	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.66e-05	0.000386	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.66e-05	0.000384	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.000383	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	1.65e-05	0.000383	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.000381	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.00038	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.64e-05	0.00038	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.63e-05	0.000378	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000377	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.63e-05	0.000377	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.62e-05	0.000376	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.61e-05	0.000374	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.61e-05	0.000373	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.61e-05	0.000372	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.6e-05	0.000371	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.6e-05	0.000371	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.59e-05	0.000369	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.58e-05	0.000366	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.57e-05	0.000364	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.56e-05	0.00036	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.55e-05	0.000359	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.51e-05	0.00035	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.5e-05	0.000349	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000348	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000348	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.000346	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000345	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.49e-05	0.000344	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.48e-05	0.000344	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000343	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000343	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000343	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000341	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.00034	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.00034	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000339	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.46e-05	0.000339	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.46e-05	0.000339	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000338	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.46e-05	0.000338	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000338	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.45e-05	0.000337	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.45e-05	0.000337	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.45e-05	0.000337	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000335	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000333	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000333	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000328	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.42e-05	0.000328	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.42e-05	0.000328	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.39e-05	0.000323	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.000323	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.37e-05	0.000317	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000314	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000313	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.35e-05	0.000313	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000311	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.34e-05	0.000311	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000311	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.34e-05	0.000311	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000309	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000307	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000307	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.32e-05	0.000305	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000305	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.29e-05	0.0003	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.29e-05	0.0003	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.28e-05	0.000298	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.28e-05	0.000298	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000296	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.27e-05	0.000295	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000294	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.26e-05	0.000293	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.26e-05	0.000293	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.26e-05	0.000292	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.26e-05	0.000292	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.000291	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000291	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000287	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000287	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000287	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.22e-05	0.000283	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.17e-05	0.00027	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.15e-05	0.000267	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.15e-05	0.000266	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.15e-05	0.000266	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000264	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000261	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.000258	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.000257	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000254	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.000253	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.08e-05	0.00025	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.08e-05	0.00025	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000249	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.06e-05	0.000246	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000242	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1e-05	0.000232	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.97e-06	0.000231	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.8e-06	0.000227	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.77e-06	0.000226	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.75e-06	0.000226	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.7e-06	0.000225	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.62e-06	0.000223	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.61e-06	0.000223	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.59e-06	0.000222	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.49e-06	0.00022	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.48e-06	0.00022	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.47e-06	0.000219	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.45e-06	0.000219	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.41e-06	0.000218	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.33e-06	0.000216	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.31e-06	0.000216	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.27e-06	0.000215	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.13e-06	0.000212	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.8e-06	0.000204	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.74e-06	0.000203	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.66e-06	0.000201	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.64e-06	0.0002	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.61e-06	0.0002	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.61e-06	0.000199	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	8.51e-06	0.000197	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.48e-06	0.000197	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.48e-06	0.000197	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.47e-06	0.000196	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.45e-06	0.000196	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.32e-06	0.000193	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.29e-06	0.000192	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	8.26e-06	0.000192	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.88e-06	0.000183	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.82e-06	0.000181	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.81e-06	0.000181	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.78e-06	0.00018	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.78e-06	0.00018	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.76e-06	0.00018	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.72e-06	0.000179	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.7e-06	0.000179	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.48e-06	0.000173	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.44e-06	0.000173	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.73e-06	0.000156	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	6.71e-06	0.000156	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.7e-06	0.000155	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.64e-06	0.000154	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.61e-06	0.000153	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	6.16e-06	0.000143	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	6.15e-06	0.000143	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.79e-06	0.000134	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.76e-06	0.000134	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.76e-06	0.000134	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.73e-06	0.000133	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.6e-06	0.00013	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.58e-06	0.000129	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.08e-06	0.000118	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.06e-06	0.000117	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5e-06	0.000116	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.99e-06	0.000116	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.98e-06	0.000115	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.97e-06	0.000115	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.9e-06	0.000114	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.87e-06	0.000113	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.6e-06	0.000107	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.59e-06	0.000106	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.56e-06	0.000106	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.55e-06	0.000105	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.53e-06	0.000105	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.4e-06	0.000102	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.37e-06	0.000101	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.96e-06	9.17e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.91e-06	9.05e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.71e-06	8.59e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.4e-06	7.89e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.39e-06	7.85e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.29e-06	7.63e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.99e-06	6.93e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.94e-06	6.82e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.93e-06	6.8e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.88e-06	6.67e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.86e-06	6.63e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.68e-06	6.2e-05	CbGpPWpGaD
